These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8636811)

  • 21. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
    Klein NP; Habanec T; Kosina P; Shah NR; Kolhe D; Miller JM; Hezareh M; Van der Wielen M
    Vaccine; 2018 Apr; 36(17):2356-2363. PubMed ID: 29576307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses.
    Granoff DM; Maslanka SE; Carlone GM; Plikaytis BD; Santos GF; Mokatrin A; Raff HV
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):479-85. PubMed ID: 9665952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.
    Lepow ML; Goldschneider I; Gold R; Randolph M; Gotschlich EC
    Pediatrics; 1977 Nov; 60(5):673-80. PubMed ID: 411104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine.
    Pereiró I; Díez-Domingo J; Morant A; Gimeno C; Lerma M; San-Martín M; González A;
    Scand J Infect Dis; 2001; 33(8):581-4. PubMed ID: 11525350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.
    McVernon J; MacLennan J; Pollard AJ; Oster P; Wakefield MJ; Danzig L; Moxon ER
    Pediatr Infect Dis J; 2003 Jul; 22(7):659-61. PubMed ID: 12886896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.
    Käyhty H; Karanko V; Peltola H; Sarna S; Mäkelä PH
    J Infect Dis; 1980 Dec; 142(6):861-8. PubMed ID: 6780634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroconversion and duration of immunity after vaccination against group C meningococcal infection in young children.
    Espín Ríos I; García-Fulgueíras A; Navarro Alonso JA; Vazquez Moreno J; Rodriguez Gonzalez T; Navarro Sánchez C; Pérez-Flores D
    Vaccine; 2000 Jun; 18(24):2656-60. PubMed ID: 10781851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Investigations on the immune response against meningococcal polysaccharide in children (author's transl)].
    Ambrosch F; Stanek G; Jürgenssen O
    Immun Infekt; 1980; 8(1):11-8. PubMed ID: 6773879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine.
    Borrow R; Richmond P; Kaczmarski EB; Iverson A; Martin SL; Findlow J; Acuna M; Longworth E; O'Connor R; Paul J; Miller E
    FEMS Immunol Med Microbiol; 2000 May; 28(1):79-85. PubMed ID: 10767611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
    Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Findlow H; Borrow R; Booy R
    Vaccine; 2018 Jul; 36(29):4375-4382. PubMed ID: 29880243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine.
    de Whalley PC; Snape MD; Kelly DF; Banner C; Lewis S; Diggle L; John TM; Yu LM; Omar O; Borkowski A; Pollard AJ
    Pediatr Infect Dis J; 2011 Nov; 30(11):e203-8. PubMed ID: 21673612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningococcal polysaccharide vaccination of military recruits in Israel: preliminary assessment of vaccine effect.
    Mimouni D; Gdalevich M; Mandel Y; Haim M; Ashkenazi I; Shemer J; Block C
    Scand J Infect Dis; 1998; 30(3):263-4. PubMed ID: 9790134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MenACWY-TT vaccine for active immunization against invasive meningococcal disease.
    Papaevangelou V; Spyridis N
    Expert Rev Vaccines; 2012 May; 11(5):523-37. PubMed ID: 22827239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine.
    Borrow R; Fox AJ; Cartwright K; Begg NT; Jones DM
    Epidemiol Infect; 1999 Oct; 123(2):201-8. PubMed ID: 10579438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of meningococcal vaccine and barriers to vaccination.
    Rosenstein N; Levine O; Taylor JP; Evans D; Plikaytis BD; Wenger JD; Perkins BA
    JAMA; 1998 Feb; 279(6):435-9. PubMed ID: 9466635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
    Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meningococcal group B vaccine trial in Norway 1981--1982. Preliminary report of results available November 1982.
    Frøholm LO; Berdal BP; Bøvre K; Gaustad P; Harboe A; Holten E; Høiby EA; Lystad A; Omland T; Frasch CE
    NIPH Ann; 1983 Dec; 6(2):133-8. PubMed ID: 6427703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group C Neisseria meningitidis variant polysaccharide vaccines in children.
    Steinhoff MC; Lewin EB; Gotschlich EC; Robbins JB
    Infect Immun; 1981 Oct; 34(1):144-6. PubMed ID: 6795122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.